A detailed history of Gqg Partners LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Gqg Partners LLC holds 436,951 shares of RDY stock, worth $6.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
436,951
Previous 436,951 -0.0%
Holding current value
$6.12 Million
Previous $33.3 Million 4.28%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$64.27 - $69.9 $18.3 Million - $20 Million
-285,497 Reduced 39.52%
436,951 $30.4 Million
Q2 2023

Aug 11, 2023

BUY
$53.34 - $63.11 $8.91 Million - $10.5 Million
167,125 Added 30.1%
722,448 $45.6 Million
Q1 2023

May 11, 2023

BUY
$51.63 - $56.93 $19.5 Million - $21.5 Million
378,011 Added 213.19%
555,323 $31.6 Million
Q2 2022

Aug 15, 2022

BUY
$49.62 - $58.13 $8.8 Million - $10.3 Million
177,312 New
177,312 $9.82 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.33B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Gqg Partners LLC Portfolio

Follow Gqg Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.